US 11814439
Anti-CD20 antibody compositions
granted A61KA61K2039/545A61K31/138
Quick answer
US patent 11814439 (Anti-CD20 antibody compositions) held by TG Therapeutics, Inc. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TG Therapeutics, Inc.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/545, A61K31/138, A61K31/167, A61K31/573